Summary
Kynuramines occur endogenously in brain and peripheral tissues as metabolites of indoleamino acids and indolamines but little is known regarding their possible physiological and/or pharmacological activity. The present study has investigated the effects of kynuramine and 5-hydroxykynuramine on the cardiovascular system of pithed rats and attempted to correlate effects seen on adrenergic and serotonergic receptors with ligand binding experiments donein vitro using rat brain membranes.
Kynuramine was found to release cardiac catecholamines and to act as a weak partial agonist on vascular alpha-adrenoceptors. Hydroxylation in the 5-position (5-hydroxykynuramine) did not alter cardiac potency but increased pressor activity 100-fold. Vasopressor responses to 5-hydroxykynuramine were mediated via a dual agonistic action on both postsynapticα 2-adrenoceptors and vascular serotonin2 receptors. These findings were supported by ligand binding studies, in which both kynuramine and 5-hydroxykynuramine showed affinity for cortical [3H]spiroperidol and [3H]clonidine binding sites. Overall, the results show that kynuramines can exert peripheral (and possibly central) actions which may prove to be of physiological and/or pharmacological significance.
Similar content being viewed by others
References
Clarke, D. E., Johnson, T. D., Charlton, K. G., Hamed, A. T.: Cardiovascular and neurochemical actions of kynuramines in rats. 5th International Catecholamine Symposium, Göteborg 1983. Progress in Neuro-Psychopharmacology, Suppl. (in press).
Dial, E. J., Clarke, D. E.: Rat and human cardiac monoamine oxidase: A comparison with other tissues. European J. Pharmacol.58, 313–319 (1979).
Fu, L. H. W., Toda, N.: Structure-activity relationship of 5-hydroxykynuramine analogues in isolated dog cerebral arteries. Jap. J. Pharmacol.29, 789–796 (1979).
Gal, E. M., Sherman, A. D.: L-Kynurenine. Its synthesis and possible regulatory function in brain. Neurochem. Res.5, 223–229 (1980).
Greengrass, P., Bremner, R.: Binding characteristics of3H-prazosin to brainα-adrenergic receptors. European J. Pharmacol.55, 323–326 (1979).
Hayaishi, O.: Indoleamine 2,3-dioxygenase. A new vista in tryptophan metabolism. Acta Vitam. Enzymol. (Milano)29, 17–20 (1975).
Hayaishi, O., Hirata, F., Fujiwara, M., Senoh, S., Tokuyama, T.: Indoleamine 2,3-dioxygenase. Note II. Biological function. Acta Vitam. Enzymol. (Milano)29, 291–293 (1975).
Johnson, T. D., Charlton, K. G., Clarke, D. E.: Cardiovascular actions of kynuramine: An endogenous metabolite of L-tryptophan. Federation Proc.42, 635 (1983).
Johnson, T. D., Clarke, D. E.: Anα-adrenoceptor inhibitory action of kynuramine. European J. Pharmacol.72, 351–356 (1981).
Johnson, T. D., Clarke, D. E.: Blood pressure and heart rate effects of kynuramine in pithed rats. European J. Pharmacol.87, 323–326 (1983).
Kuhn, D. M., Wolf, W. A., Lovenberg, W.: Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension2, 243–255 (1980).
Makino, K., Takahashi, H.: Action of dimethylkynurenamine on blood pressure. Science120, 544–545 (1954).
Makino, K., Takahashi, H.: The synthesis of dimethyl 5-hydroxykynurenamine and its action on the blood pressure of rabbit. J. Biochem. (Tokyo)42, 559–560 (1955).
Marangos, P. J., Patel, J., Hirata, F., Sondhein, D., Paul, S. M., Skolnick, P., Goodwin, F. K.: Inhibition of diazepam binding by tryptophan derivatives including melatonin and its brain metabolite N-acetyl-5-methoxy kynurenamine. Life Sci.29, 259–267 (1981).
Peroutka, S. J., Noguchi, M., Tolner, D. J., Allen, G. S.: Serotonin-induced contraction of canine basilar artery: Mediation by 5-HT1 receptors. Brain Res.259, 327–330 (1983).
Peroutka, S. J., Snyder, S. H.: Two distinct serotonin receptors: Regional variations in receptor binding in mammalian brain. Brain Res.208, 339–347 (1981).
Peroutka, S. J., Snyder, S. H.: Multiple serotonin receptors and their physiological significance. Federation Proc.42, 213–217 (1983).
Sved, A. F., Van Itallie, C. M., Fernstrom, J. D.: Studies on the antihypertensive action of L-tryptophan. J. Pharmacol. Exp. Ther.221, 329–333 (1982).
U'Pritchard, D. C., Greenberg D. A., Snyder, S. H.: Binding characteristics of a radiolabeled agonist and antagonist at central nervous systemα-nor-adrenergic receptors. Mol. Pharmacol.13, 454–473 (1977).
Williams, M., Martin, G. E.: Selectivity of cyproheptadine as assessed by radioligand binding. J. Pharm. Pharmacol.34, 58–59 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Charlton, K.G., Johnson, T.D., Hamed, A.T. et al. Cardiovascular actions of kynuramine and 5-hydroxykynuramine in pithed rats. J. Neural Transmission 57, 199–211 (1983). https://doi.org/10.1007/BF01248993
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01248993